InnoCan Pharma (TSE:INNO) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts and uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Innocan Pharma is set to raise up to C$700,000 through a private placement of units, with each unit consisting of one common share and one warrant. The funds will be directed towards working capital and corporate purposes, as the company continues to innovate in the pharmaceuticals and wellness sectors.
For further insights into TSE:INNO stock, check out TipRanks’ Stock Analysis page.
